引用本文:于艳丽,熊艳杰,田志华,宋志超,韩 萍.上皮性卵巢癌DNA-PKcs和ERCC1表达与预后相关因素分析[J].中国临床新医学,2013,6(6):519-523.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1428次   下载 940 本文二维码信息
码上扫一扫!
分享到: 微信 更多
上皮性卵巢癌DNA-PKcs和ERCC1表达与预后相关因素分析
于艳丽,熊艳杰,田志华,宋志超,韩 萍
063021 河北,唐山市开平医院妇产科(于艳丽);063000 唐山,河北联合大学附属医院病理科(熊艳杰),妇科(韩 萍);062550 河北,任丘市华北油田二部医院妇产科(田志华,宋志超)
摘要:
[摘要] 目的 探讨原发上皮性卵巢癌组织中DNA-PKcs和ERCC1表达与卵巢癌预后的关系。方法 采用免疫组化SP法检测99例上皮性卵巢癌和16例正常卵巢组织中DNA-PKcs和ERCC1的表达。结果 DNA-PKcs和ERCC1在卵巢癌组织中的阳性率分别为60.61%和53.54%,均显著高于正常卵巢组织(P<0.01);DNA-PKcs和ERCC1表达呈显著正相关(r=0.408,P=0.000)。单因素分析显示,DNA-PKcs与ERCC1共表达,FIGO分期、淋巴结转移、CA125半衰期、残留灶直径均与卵巢癌患者的生存时间有关(P<0.05)。多因素分析显示,ERCC1表达、FIGO分期、淋巴结转移与残留灶直径均是影响卵巢癌预后的独立危险因素。结论 DNA-PKcs和ERCC1在上皮性卵巢癌组织中表达率明显高于正常卵巢组织;联合检测DNA-PKcs与ERCC1表达可作为早期诊断及预测卵巢癌预后的指标。
关键词:  DNA-PKcs  ERCC1  上皮性卵巢癌  预后
DOI:10.3969/j.issn.1674-3806.2013.06.04
分类号:R 737.31
基金项目:唐山市科技局科技攻关计划应用项目(编号:121302109a)
The expression of DNA-PKcs and ERCC1 in epithelial ovarian cancer and its prognostic significance
YU Yan-li, XIONG Yan-jie, TIAN Zhi-hua, et al.
Department of Gynecology, Tangshan Kaiping Hospital, Hebei 063021, China
Abstract:
[Abstract] Objective To explore the relationship of the expression of DNA-PKcs and ERCC1 in primary epithelial ovarian cancer with the prognosis ovarian cancer.Methods Expressions of DNA-PKcs and ERCC1 were detected in 99 samples of epithelial ovarian cancer tissues, 16 samples of normal ovary tissues by immunohistochemical SP method.Results The positive rates of DNA-Pkcs and ERCC1 expression in epithelial ovarian cancer patients were 60.61%(60/99) and 53.54%(53/99) respectively, the positive rates of DNA-PKcs and ERCC1 in epithelial ovarian cancer tissues were apparently highter than normal ovary tissues(P<0.01); The expressions between DNA-PKcs and ERCC1 showed positive correlation(r=0.408, P=0.000); Single factor Kaplan-Meier analysis showed that the expressions of DNA-PKcs and ERCC1, the co-expression of DNA-Pkcs and ERCC1, the FIGO stage, lymph node metastasis, the half-life of serum CA125 and the diameter of residual tumor were correlated with the average survival time in ovarian cancer patients(P<0.05). The expression of ERCC1, FIGO stage, lymph node metastasis and the diameter of residual tumor were related to the independent risk factors of ovarian cancer prognosis revealed by Cox multiple factors survival analysis.Conclusion The positive expression rates of DNA-Pkcs and ERCC1 in epithelial ovarian cancer patients were significantly higher than that in normal ovarian tissues; The combined detection of DNA-PKcs and ERCC1 in epithelial ovarian cancer patients is maybe a new target for early diagnosis and prediction of outcome for this disease.
Key words:  DNA-PKcs  ERCC1  Epithelial ovarian cancer  Prognosis